Mast cell numbers and protease expression patterns in biopsy specimens following renal transplantation from living-related donors predict long-term graft function

Clinical Transplantation

Volumn 19, Issue 6, 2005, Pages 817-824

  Ishida, Toshiro ^a   Hyodo, Yoji ^a   Ishimura, Takeshi ^b   Takeda, Masashi ^a   Hara, Isao ^a   Fujisawa, Masato ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Fibrosis; Mast cell; Renal transplantation; Subtype

Indexed keywords

15 DEOXYSPERGUALIN; CHYMASE; CREATININE; CYCLOSPORIN A; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; MIZORIBINE; PROTEINASE; TRYPTASE;

ACUTE GRAFT REJECTION; ARTICLE; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE CLEARANCE; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY TRANSPLANTATION; LIVING DONOR; MAST CELL; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BIOPSY; CATHEPSINS; CELL COUNT; CHYMASES; FIBROSIS; GRAFT REJECTION; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY TRANSPLANTATION; LIVING DONORS; MAST CELLS; POSTOPERATIVE PERIOD; SERINE ENDOPEPTIDASES; TIME FACTORS; TRYPTASES;

EID: 28644435728     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2005.00427.x     Document Type: Article

References (35)

1. Kahan BD. Cyclosporine. N Engl J Med 1989: 321: 1725.
2. Burke JF, Pirsch JD, Ramos EL et al. Long-term efficacy and safety of cyclosporine in renal transplant recipients. N Engl J Med 1994: 331: 358.
3. Carpenter CB. Long-term failure of renal transplants; adding insult to injury. Kidney Int 1995: 48(Suppl. 50): S40.
4. Paul LC. Chronic renal transplant loss. Kidney Int 1995: 47: 1491.
5. The Canadian Multicenter Transplant Study Group. A randomized trial of cyclosporine in cadavaric renal transplantation. N Engl J Med 1983: 309: 809.
6. Bia MJ. Nonimmunologic causes of late renal graft loss. Kidney Int 1995: 47: 1470.
7. Racusen LC, Solez KIM, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999: 55: 713.
8. Kasiske BL, Kalil RS, Lee HS, Rao KV. Histopathologic findings associated with a chronic progressive decline in renal allograft function. Kidney Int 1991: 40: 514.
9. Bruijn JA, Hogendoorn PCW, Hoedemaeker PJ, Fleuren GJ. The extracellular matrix in pathology. J Lab Clin Med 1988: 111: 140.
10. Kawanami O, Ferrans VJ, Fulmer JD, Crystal RG. Ultrastructure of pulmonary mast cells in patients with fibrotic lung disorders. Lab Invest 1979: 40: 717.
11. Irani AA, Schechter NM, Craig SS, DeBlois G, Schwartz LB. Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci USA 1986: 83: 4464.
12. Weidner N, Austin KF. Heterogeneity of mast cells at multiple body sites; fluorescent determination of avidin binding and immunofluorescent determination of chymase, tryptase and carboxypeptidase content. Pathol Res Pract 1993: 189: 156.
13. Irani AA, Schwartz LB. Human mast cell heterogeneity. Allergy Proc 1994: 15: 303.
14. Pardo J, Diaz L, Errasti P et al. Mast cells in chronic rejection of human renal allografts. Virchows Arch 2000: 437: 167.
15. Lajoie G, Nadasdy T, Laszik Z, Blick KE, Silva FG. Mast cells in acute cellular rejection of human renal allografts. Mod Pathol 1996: 12: 1118.
16. Yamada M, Ueda M, Naruko T et al. Mast cell chymase expression and mast cell phenotypes in human rejected kidneys. Kidney Int 2001: 59: 1374.
17. Roberts ISD, Brenchley PEG. Mast cells: the forgotten cells of renal fibrosis. J Clin Pathol 2000: 53: 858.
18. Rush DN, Henry SF, Jeffery JR, Schroeder TJ, Gough J. Histological findings in early routine biopsies of stable renal allograft recipients. Transplantation 1994: 57: 208.
19. Isoniemi HM, Krogerus L, Von Willebrand E, Taskinen E, Ahonen J, Hayry P. Histopathological findings in well-functioning, long-term renal allografts. Kidney Int 1992: 41: 155.
20. Rush DN, Jeffery JR, Gough J. Sequential protocol biopsies in renal transplant patients. Transplantation 1995: 59: 511.
21. Fujisawa M, Ono H, Isotani S et al. Significance of chronic transplant nephropathy on early protocol biopsies for graft outcome in pediatric renal transplantation. Transplant Proc 1999: 31: 1678.
22. Cairns JA, Walls AF. Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. J Clin Invest 1997: 99: 1313.
23. Gruber BL, Kew RR, Jelaska A et al. Human mast cell activate fibroblasts; tryptase is a fibrogenic factor stimulating collagen messenger ribonucleic acid synthesis and fibroblast chemotaxis. J Immunol 1997: 158: 2310.
24. Kofford MW, Schwartz LB, Schechter NM, Yager DR, Diegelmann RF, Graham MF. Cleavage of type I procollagen by human mast cell chymase initiates collagen fibre formation and generates a unique carboxyl-terminal propeptide. J Biol Chem 1997: 272: 7127.
25. Bradding P, Okayama Y, Howarth PH, Church MK, Holgate ST. Heterogeneity of human mast cells based on cytokine content. J Immunol 1995: 155: 297.
26. Craig SS, Schechter NM, Schwartz LB. Ultrastructural analysis of human T and TC mast cells identified by immunoelectron microscopy. Lab Invest 1988: 58: 682.
27. Irani AA, Sampson HA, Schwartz LB. Mast cell in atopic dermatitis. Allergy 1989: 44: 31.
28. Kankkunen JP, Harvima IT, Naukkarinen A. Quantitative analysis of tryptase and chymase containing mast cells in benign and malignant breast lesions. Int J Cancer 1997: 72: 385.
29. TC type. Clin Exp Allergy 1990: 20: 53.
30. Yousem SA. The potential role of mast cells in lung allograft rejection. Hum Pathol 1997: 28: 179.
31. Walgenbach KJ, Heeckt PF, Stanson JD, Whiteside TL, Bauer AJ. Increased presence of mast cells and interleukin-4 during chronic rejection of rat interstinal allografts. Transplant Proc 1996: 28: 2454.
32. Kormendi F, Amend WJ Jr. The importance of eosinophil cells in kidney allograft rejection. Transplantation 1988: 45: 537.
33. Urata H, Kinoshita A, Misono KS, Bumpus FM, Husain A. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem 1990: 265: 22348.
34. Border WA, Noble NA. Interactions of transforming growth factor-β and angiotensin II in renal fibrosis. Hypertension 1998: 31: 181.
35. Kaneto H, Morrissey J, Klahr S. Increased expression of TGF-β1 mRNA in the obstructed kidney of rats with unilateral ligation. Kidney Int 1933: 44: 313.